CompaniesAmbrilia Biopharma

Ambrilia Biopharma

defunct
About

Defunct Company

Areas of Focus

Categories

BankruptBankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (4)
View all

Total Trials

4

As Lead Sponsor

3

As Collaborator

1

Total Enrollment

204

By Phase

PHASE3: 3PHASE1: 1

By Status

COMPLETED: 3TERMINATED: 1
Clinical Trials Pipeline4 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2004
2005
2006
2007
2008
2009
2010
Today
NCT00695851
NCT00635765
NCT00642421
Hover over trial bars to see details

Recent Trials

NCT00642421Lead Sponsor
Safety and Biological Activity of C2L-OCT-01 PR in Acromegalic Patients
PHASE3Terminated
40 participants
Started: Feb 29, 2008 · Completed: Aug 31, 2009
NCT00635765Lead Sponsor
Open Label Extension Study Evaluating Safety and Biological Activity of C2L-OCT-01 PR in Acromegalic Patients
PHASE3Completed
63 participants
Started: Oct 31, 2007 · Completed: Jun 30, 2009
NCT00616551Lead Sponsor
Efficacy and Safety of C2L-OCT-01 PR in Acromegalic Patients
PHASE3Completed
65 participants
Started: Apr 30, 2007 · Completed: Feb 29, 2008
NCT00695851Collaborator
Dose-Seeking Trial of PCK3145 in Asymptomatic, Castrate Metastatic Prostate Cancer Patients.
PHASE1Completed
36 participants
Started: Mar 31, 2005 · Completed: Mar 31, 2009